Anna Sundlöv

1.3k total citations
41 papers, 845 citations indexed

About

Anna Sundlöv is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Anna Sundlöv has authored 41 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 29 papers in Oncology and 16 papers in Neurology. Recurrent topics in Anna Sundlöv's work include Neuroendocrine Tumor Research Advances (30 papers), Lung Cancer Research Studies (27 papers) and Neuroblastoma Research and Treatments (16 papers). Anna Sundlöv is often cited by papers focused on Neuroendocrine Tumor Research Advances (30 papers), Lung Cancer Research Studies (27 papers) and Neuroblastoma Research and Treatments (16 papers). Anna Sundlöv collaborates with scholars based in Sweden, Norway and Denmark. Anna Sundlöv's co-authors include Katarina Sjögreen Gleisner, Jan Tennvall, Johanna Svensson, Peter Bernhardt, Michael Ljungberg, Johan Gustafsson, Daniel Roth, Juan Manuel Sepúlveda-Sánchez, Daniel Castellano and H. Cortés-Funes and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Cancer.

In The Last Decade

Anna Sundlöv

39 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Sundlöv Sweden 15 439 420 413 246 131 41 845
Johanna Svensson Sweden 16 355 0.8× 509 1.2× 272 0.7× 171 0.7× 156 1.2× 38 792
Silvia M. Baio Italy 10 745 1.7× 383 0.9× 679 1.6× 455 1.8× 119 0.9× 16 1.1k
Marianne E. Pavel Germany 5 564 1.3× 256 0.6× 470 1.1× 369 1.5× 98 0.7× 11 748
Nicolas Marincek Switzerland 10 792 1.8× 217 0.5× 662 1.6× 546 2.2× 61 0.5× 11 944
Ina Binse Germany 14 335 0.8× 378 0.9× 307 0.7× 223 0.9× 93 0.7× 35 849
Laura Gilardi Italy 11 195 0.4× 158 0.4× 309 0.7× 148 0.6× 86 0.7× 36 514
Tessa Brabander Netherlands 19 1.1k 2.4× 371 0.9× 984 2.4× 808 3.3× 236 1.8× 54 1.5k
J. Gains United Kingdom 14 177 0.4× 127 0.3× 128 0.3× 388 1.6× 123 0.9× 34 587
Patrick McNeillie United States 6 298 0.7× 169 0.4× 312 0.8× 207 0.8× 183 1.4× 13 680
A. Di Dia Italy 13 113 0.3× 523 1.2× 162 0.4× 50 0.2× 263 2.0× 30 741

Countries citing papers authored by Anna Sundlöv

Since Specialization
Citations

This map shows the geographic impact of Anna Sundlöv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Sundlöv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Sundlöv more than expected).

Fields of papers citing papers by Anna Sundlöv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Sundlöv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Sundlöv. The network helps show where Anna Sundlöv may publish in the future.

Co-authorship network of co-authors of Anna Sundlöv

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Sundlöv. A scholar is included among the top collaborators of Anna Sundlöv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Sundlöv. Anna Sundlöv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sørbye, Halfdan, Geir Olav Hjortland, Lene Weber Vestermark, et al.. (2025). Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study. British Journal of Cancer. 133(3). 316–324. 8 indexed citations
2.
Sundlöv, Anna, et al.. (2024). Optimal follow‐up with somatostatin receptor PET / CT imaging in patients with small intestinal neuroendocrine tumours. Journal of Neuroendocrinology. 36(8). e13396–e13396. 1 indexed citations
3.
Sørbye, Halfdan, Geir Olav Hjortland, Anna Sundlöv, et al.. (2024). NETest in advanced high‐grade gastroenteropancreatic neuroendocrine neoplasms. Journal of Neuroendocrinology. 36(11). e13428–e13428. 3 indexed citations
4.
Gustafsson, Johan, Daniel Roth, Jan Tennvall, et al.. (2024). Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE. Journal of Nuclear Medicine. 65(7). 1070–1075. 15 indexed citations
5.
6.
Langer, Seppo W., Anna Sundlöv, Lene Weber Vestermark, et al.. (2023). Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms. British Journal of Cancer. 129(12). 1930–1939. 11 indexed citations
7.
Knappskog, Stian, Tobias Grob, Ursula Amstutz, et al.. (2023). Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma. JCO Precision Oncology. 7(7). e2200336–e2200336. 12 indexed citations
8.
Enqvist, Olof, et al.. (2023). AI-based quantification of whole-body tumour burden on somatostatin receptor PET/CT. SHILAP Revista de lepidopterología. 7(1). 14–14. 5 indexed citations
9.
Trägårdh, Elin, et al.. (2022). Relationship between somatostatin receptor expressing tumour volume and health‐related quality of life in patients with metastatic GEP‐NET. Journal of Neuroendocrinology. 34(6). e13139–e13139. 3 indexed citations
10.
Sørbye, Halfdan, Stian Knappskog, Tobias Grob, et al.. (2022). 890MO Mutation spectrum in liquid versus solid biopsies from advanced digestive neuroendocrine carcinoma patients. Annals of Oncology. 33. S955–S955. 1 indexed citations
11.
Pommergaard, Hans‐Christian, Halfdan Sørbye, Birgitte Federspiel, et al.. (2021). Surgery of the primary tumour in 201 patients with high‐grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine‐non‐neuroendocrine neoplasms. Journal of Neuroendocrinology. 33(5). e12967–e12967. 32 indexed citations
12.
Perren, Aurel, Geir Olav Hjortland, Anna Sundlöv, et al.. (2020). Mutational Landscape of 109 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms G3. Neuroendocrinology. 110. 2 indexed citations
13.
Roth, Daniel, Erik Larsson, Anna Sundlöv, & Katarina Sjögreen Gleisner. (2020). Characterisation of a hand-held CZT-based gamma camera for 177Lu imaging. EJNMMI Physics. 7(1). 46–46. 8 indexed citations
14.
Sundlöv, Anna & Katarina Sjögreen Gleisner. (2020). Peptide Receptor Radionuclide Therapy – Prospects for Personalised Treatment. Clinical Oncology. 33(2). 92–97. 11 indexed citations
15.
Almquist, Helén, Martin Almquist, Cécilia Hindorf, et al.. (2019). A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on68Ga-DOTATATE Uptake in Patients with Neuroendocrine Tumors. Journal of Nuclear Medicine. 60(12). 1717–1723. 23 indexed citations
16.
Lindgren, Ola, Anna Sundlöv, Jan Tennvall, et al.. (2019). The Effect of Radioiodine Treatment on TRAb, Anti-TPO, and Anti-TG in Graves’ Disease. European Thyroid Journal. 8(2). 64–69. 9 indexed citations
17.
Svensson, Johanna, Tobias Rydèn, Martijn van Essen, et al.. (2019). Bone Marrow Absorbed Doses and Correlations with Hematologic Response During 177Lu-DOTATATE Treatments Are Influenced by Image-Based Dosimetry Method and Presence of Skeletal Metastases. Journal of Nuclear Medicine. 60(10). 1406–1413. 54 indexed citations
18.
Jönsson, Lena, et al.. (2018). Quantitative analysis of phantom studies of 111In and 68Ga imaging of neuroendocrine tumours. EJNMMI Physics. 5(1). 5–5. 11 indexed citations
19.
Feliú, Jaime, Guillermo Martı́n, Javier de Castro, et al.. (2006). Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 58(4). 527–531. 5 indexed citations
20.
Sundlöv, Anna, et al.. (2004). Anticuerpos contra el cáncer. Revista Clínica Española. 204(12). 649–654. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johanna Svensson Breakdown of academic impact, for papers by Silvia M. Baio Breakdown of academic impact, for papers by Marianne E. Pavel Breakdown of academic impact, for papers by Nicolas Marincek Breakdown of academic impact, for papers by Ina Binse Breakdown of academic impact, for papers by Laura Gilardi Breakdown of academic impact, for papers by Tessa Brabander Breakdown of academic impact, for papers by J. Gains Breakdown of academic impact, for papers by Patrick McNeillie Breakdown of academic impact, for papers by A. Di Dia
Rankless by CCL
2026